Andrew W. Hardy

发表

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

D. Fuchs, A. Boasso, J. Herbeuval, 2007, Blood.

CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.

J. Lifson, C. Chougnet, J. Grivel, 2005, Blood.

Non-toxic inhibition of HIV-1 replication with silver–copper nanoparticles

C. Eddy, A. Boasso, Andrew W. Hardy, 2010, Medicinal Chemistry Research.

HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation

A. Boasso, Andrew W. Hardy, S. Anderson, 2008, PloS one.

bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use

J. Lifson, C. Chougnet, L. Havekes, 2004 .

Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo

Andrew W. Hardy, G. Shearer, M. Poirier, 2009, AIDS research and therapy.

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

A. Boasso, J. Herbeuval, Andrew W. Hardy, 2005, Blood.

HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α

D. Graham, J. Herbeuval, Andrew W. Hardy, 2007, Proceedings of the National Academy of Sciences.

Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

M. Kruhlak, J. Andersson, A. Boasso, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression.

S. Rybak, A. Boasso, Andrew W. Hardy, 2006, AIDS research and human retroviruses.

tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells Regulation of indoleamine 2,3-dioxygenase and

A. Boasso, J. Herbeuval, Andrew W. Hardy, 2013 .

TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells.

J. Lifson, C. Chougnet, J. Grivel, 2005, Blood.

2,3-dioxygenase in plasmacytoid dendritic cells HIV inhibits CD4+ T-cell proliferation by inducing indoleamine

D. Fuchs, A. Boasso, J. Herbeuval, 2013 .

type I interferon-dependent, TRAIL/DR5-mediated apoptosis CD4+ T cell death induced by infectious and noninfectious HIV-1: role of

J. Lifson, C. Chougnet, J. Grivel, 2013 .

Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

A. Boasso, J. Herbeuval, Andrew W. Hardy, 2005, Proceedings of the National Academy of Sciences of the United States of America.

PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.

M. Clerici, A. Boasso, Andrew W. Hardy, 2008, Clinical immunology.

Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques1

D. Fuchs, M. Vaccari, A. Boasso, 2009, The Journal of Immunology.

HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques

J. Andersson, M. Vaccari, A. Boasso, 2009, AIDS.

WR1065 mitigates AZT‐ddI‐induced mutagenesis and inhibits viral replication

J. Swenberg, Andrew W. Hardy, G. Shearer, 2009, Environmental and molecular mutagenesis.